Skip to main content

Animations

MJFF Publications

7711 - 7720 of 8819 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2011
  • 2015
  • 2016
  • 2014
  • 2011
  • 2012
  • 2013
  • 2017
  • Summary Details
    RESTRICTED
    Title: Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11682-018-9920-2
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: What’s the target: understanding two decades of in silico microRNA-target prediction
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/bib/bbz111
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0b013e31821300bc
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2015.05.004
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Cross‐validation of optimized composites for preclinical Alzheimer's disease
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1242/jcs.079293
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Validation of nigrostriatal positron emission tomography measures: Critical limits
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.23798
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.23939
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease
    Journal Name: The Journal of Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/path.4929
    Citation Count: 127
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.